Hepion Pharmaceuticals, Inc. (HEPA)

Hepion Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-38.52	-48.93	-45.34	-32.72	-20.36	-12.48
Depreciation & Amortization	0.08	0.07	0.08	0.09	0.03	0.03
Share-Based Compensation	0.12	1.34	2.55	4.67	2.38	0.07
Other Operating Activities	2.03	6.63	4.61	-3.26	1.77	-0.62
Operating Cash Flow	-36.29	-40.89	-34.96	-31.22	-16.17	-7.57
Capital Expenditures	-0.01	-0.01	-0.01	-0.13	-0.09	-0.05
Investing Cash Flow	-0.01	-0.01	-0.01	-0.13	-0.09	-0.05
Share Issuance / Repurchase	6.34	4.49	0	82.15	42.88	9.77
Debt Issued / Paid	0	0	0	-0.18	0.18	-1.12
Other Financing Activities	-	-	-5.14	-	-	10.05
Financing Cash Flow	6.34	4.49	-5.14	81.98	43.05	18.71
Exchange Rate Effect	0.07	0.01	-0.05	0	0	0
Net Cash Flow	-29.89	-36.4	-40.16	50.62	26.8	11.09
Free Cash Flow	-36.31	-40.9	-34.98	-31.35	-16.25	-7.62
Free Cash Flow Per Share	-7.16	-10.30	-9.18	-8.92	-33.58	-74.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).